Evidence map›Paper›PMID 28188157›Full record

ArticleBioscience reports2017

microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.

Dawei Wang, Guoliang Lu, Yuan Shao, Da Xu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Dysfunction of miR-802 in tumors.Journal of clinical laboratory analysis · 2021
    Review
  4. Review
  5. Article
  6. Flotillin membrane domains in cancer.Cancer metastasis reviews · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The effects of growth hormone on therapy resistance in cancer.Cancer drug resistance (Alhambra, Calif.) · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dawei WangDepartment of Urology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Guoliang LuDepartment of Urology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yuan ShaoDepartment of Urology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, China shaoyuan1602@163.com daxu@medmail.com.cn.
Da XuDepartment of Urology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai, China shaoyuan1602@163.com daxu@medmail.com.cn.
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs are a class of non-coding RNAs that exert critical roles in various biological processes. The aim of the present study was to identify the functional roles of

Indexed as

Gene Expression Regulation, Neoplastic3' Untranslated RegionsAnimalsApoptosisBlotting, WesternCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionHumansMaleMembrane ProteinsMice, Inbred BALB CMicroRNAsMiddle AgedProstatic Neoplasms3' Untranslated RegionsflotillinsMembrane ProteinsMicroRNAsMIRN802 microRNA, humanepithelial-mesenchymal transitionFlot2metastasismicroRNA-802prostate cancer

Identifiers

PMID28188157
PMCPMC5350603
OpenAlexW2587445524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.